Related Experiment Video
Updated: Jun 18, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
L Alex Gaither1, Jason Borawski, Leah J Anderson
1Novartis Institutes of Biomedical Research, Cambridge, MA 02139, USA.
Abstract:
Three cyclophilin inhibitors (DEBIO-025, SCY635, and NIM811) are currently in clinical trials for hepatitis C therapy. The mechanism of action of these, however, is not completely understood. There are at least 16 cyclophilins expressed in human cells which are involved in a diverse set of cellular processes. Large-scale siRNA experiments, chemoproteomic assays with cyclophilin binding compounds, and mRNA profiling of HCV replicon containing cells were used to identify the cyclophilins that are instrumental to HCV replication. The previously reported cyclophilin A was confirmed and additional cyclophilin containing pathways were identified. Together, the experiments provide strong evidence that NIM811 reduces viral replication by inhibition of multiple cyclophilins and pathways with protein trafficking as the most strongly and persistently affected pathway.
Insights
Hepatitis C drug NIM811 inhibits viral replication by targeting multiple cyclophilins and cellular pathways, particularly protein trafficking. Further research is needed to fully understand its mechanism of action.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Cyclophilin inhibitors like DEBIO-025, SCY635, and NIM811 are in clinical trials for hepatitis C.
- The precise mechanism of action for these cyclophilin inhibitors is not fully elucidated.
- Human cells express at least 16 cyclophilins involved in various cellular functions.
Purpose of the Study:
- To identify specific cyclophilins crucial for hepatitis C virus (HCV) replication.
- To elucidate the mechanism of action of NIM811 in inhibiting HCV.
- To investigate the cellular pathways affected by NIM811.
Main Methods:
- Large-scale siRNA screening to identify essential cyclophilins.
- Chemoproteomic assays using cyclophilin-binding compounds.
- mRNA profiling of cells containing HCV replicons.
Main Results:
- Confirmed the role of cyclophilin A in HCV replication.
- Identified additional cyclophilin-containing pathways involved in HCV.
- NIM811 demonstrated inhibition of multiple cyclophilins and pathways.
- Protein trafficking was identified as the most significantly impacted pathway by NIM811.
Conclusions:
- NIM811 exerts its antiviral effect by inhibiting multiple cyclophilins.
- The inhibition of protein trafficking is a key mechanism by which NIM811 reduces HCV replication.
- These findings contribute to understanding cyclophilin inhibitor mechanisms for hepatitis C therapy.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
cAMP-dependent Protein Kinase Pathways
Inhibitors of Viral Protein Synthesis
Hepatitis

